# A Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) in India (MK-7962-037)

> clinical trial · VERIFIED · 2026-06-29

Status: NOT_YET_RECRUITING · Sponsor: Merck Sharp & Dohme LLC · Condition: Pulmonary Arterial Hypertension

- Company: Merck Sharp & Dohme LLC
- Sector: cardiology
- Primary source: https://clinicaltrials.gov/study/NCT07600723

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.